Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients
- 1 May 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (5) , 2054-2061
- https://doi.org/10.1046/j.1523-1755.1999.00437.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Major determinants of hyperhomocysteinemia in peritoneal dialysis patientsKidney International, 1998
- The Role of Homocysteine in End‐Stage Renal DiseaseSeminars in Dialysis, 1998
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- Hyperhomocysteinemia: detection, risk assessment, and treatmentCurrent Opinion in Nephrology and Hypertension, 1997
- Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patientsKidney International, 1997
- Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomesKidney International, 1997
- Homocysteine and Thrombotic DiseaseBlood, 1997
- Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine ConcentrationsCirculation, 1996
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Plasma amino acid abnormalities in chronic renal failureClinica Chimica Acta; International Journal of Clinical Chemistry, 1972